News J&J says ready to fend off Remicade competitor Pfizer's rival launch should be considered "at risk", says J&J
News Pfizer set for US launch of Remicade biosimilar Pfizer gearing up for US launch late next month.
News J&J's long-lasting diabetes combo approved in US Company looks to new drugs as US Remicade competition looms.
News Sandoz's Enbrel biosimilar approved in US FDA approves first near-copy of inflammatory diseases drug.
News Mylan and Biocon file Herceptin biosimilar in Europe First Herceptin biosimilar filed in EU, companies say.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
